PR Newswire
Johnson & Johnson Teams Up with Naomi Watts to Reveal Why an Eye Exam is the Ultimate Self-Care Move for Women Over 40
📈
AI Sentiment
Highly Positive
8/10
Johnson & Johnson News
Latest updates and market news for JNJ
20 news
Nov 28 - Dec 4, 2025
Page 1
Insider Monkey
Johnson & Johnson’s (JNJ) Multiple Myeloma Breakthrough Drives Buy Rating From Guggenheim
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Medication Adherence Research Report 2025: Market to Reach $3.63 Billion by 2030, Driven by Rising Chronic Disease Burden, Aging Populations, and Growing Adoption of Digital Health Tools
📈
AI Sentiment
Highly Positive
8/10
Zacks
JNJ Gets EU Nod for Imaavy in Generalized Myasthenia Gravis
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
LifeStyles Healthcare Appoints Peter Luther to Board of Directors
📈
AI Sentiment
Highly Positive
8/10
Barrons.com
Exxon and 15 More ‘Quality’ Stocks to Own for a Volatile Market
➖
AI Sentiment
Neutral
5/10
24/7 Wall St.
Time to Shore Up Your Personal Portfolio With These 3 Bullet-Proof Blue-Chip Stocks
📊
AI Sentiment
Positive
6/10
MT Newswires
Barclays Adjusts Price Target on Johnson & Johnson to $197 From $176, Maintains Equalweight Rating
📊
AI Sentiment
Positive
6/10
Zacks
Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus
📊
AI Sentiment
Positive
7/10
PR Newswire
National Veterinary Associates Appoints Leslie Storms as President, Ethos Veterinary Health
📈
AI Sentiment
Highly Positive
8/10
MedTech Dive
J&J’s US orthopedic leader leaves amid DePuy spinout process
➖
AI Sentiment
Neutral
5/10
Insider Monkey
Analysts Note Stronger Outlook as Kimberly-Clark (KMB) Deepens Its Consumer Health Footprint
📊
AI Sentiment
Positive
7/10
Insider Monkey
JNJ to Acquire Halda Therapeutics for $3.05 Billion to Boost Oncology Pipeline
📊
AI Sentiment
Positive
7/10
Motley Fool
3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio
📊
AI Sentiment
Positive
7/10
Insider Monkey
Jim Cramer Says He is “Particularly Fond” of Johnson & Johnson
📈
AI Sentiment
Highly Positive
8/10
Zacks
JNJ's Oncology Momentum Builds as It Chases $50B Goal by 2030
📈
AI Sentiment
Highly Positive
8/10
Share this news page